SIGA Technologies

SIGA Technologies, Inc.
TypePublic
Nasdaq: SIGA
Russell 2000 Component
IndustryHealthcare
Biotechnology
Health security
FoundedDecember 28, 1995 (1995-12-28)
Headquarters,
United States
Key peopleDiem Nguyen, Ph.D. (CEO)
Dennis E. Hruby, Ph.D. (CSO)
ProductsPharmaceutical agents
RevenueIncrease $133.7 million (2021)
Increase $89.1 million (2021)
Increase $69.5 million (2021)
Number of employees
39 (2022)
Websitesiga.com
Footnotes

SIGA Technologies, Inc. is an American pharmaceutical company founded in 1995, based in New York City, which develops and sells pharmaceutical solutions for the antiviral treatment of smallpox, monkeypox, cowpox, and vaccinia complications.